## Background: Ifosfamide is successfully employed in the treatment of bone and soft tissue sarcomas in children and young adults. used at high doses (hdi) the drug may cause severe multiorgan toxicity. peripheral neuropathy is a less well-known side effect that may limit its use. we describe a 16-
Painful peripheral neuropathy and its nonsurgical treatment
β Scribed by Gil I. Wolfe; Jaya R. Trivedi
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 153 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0148-639X
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Treatment of neuropathic pain is the primary focus of management for many patients with painful peripheral neuropathy. Antidepressants and anticonvulsants are the two pharmacological classes most widely studied and represent firstβline agents in the management of neuropathic pain. The number of pharmacological agents that have demonstrated effectiveness for neuropathic pain continues to expand. In the current review, we summarize data from randomized, controlled pharmacological trials in painful peripheral neuropathies. Although neuropathic pain management remains challenging because the response to therapy varies considerably between patients, and pain relief is rarely complete, a majority of patients can benefit from monotherapy using a wellβchosen agent or polypharmacy that combines medications with different mechanisms of action. Muscle Nerve 30: 3β19, 2004
π SIMILAR VOLUMES
Around one of three diabetic patients is affected by distal symmetric polyneuropathy (DSP) which represents a major health problem, as it may present with partly excruciating neuropathic pain and is responsible for substantial morbidity and increased mortality. Treatment is based on four cornerstone